2
Cancer is a mitochondrial metabolic disease driven by impaired respiration and compensatory glucose/glutamine fermentation, not primarily nuclear mutations. Management centers on press-pulse metabolic therapy: lowering glucose and glutamine, raising ketones, and combining diet, fasting, hyperbaric oxygen, and targeted drug pulses.
A presentation by Professor Thomas Seyfried recorded during the March 2026 Grand Rounds of the Australasian Metabolic Health Society
summerizer
Mitochondrial origin of cancer
- The mitochondrial-metabolic model links cancer to chronic damage in oxidative phosphorylation as the origin of malignant behavior.
- The somatic mutation theory is weakened by tumor nuclei regaining regulated growth in normal cytoplasm, while tumor cytoplasm drives death or dysregulated growth.
- Nuclear-transfer experiments in frogs, medulloblastoma mice, and melanoma mice place the decisive cancer defect outside the nucleus.
- The National Cancer Institute definition keeps cancer inside a genetic-disease view, while the lecture places the core defect in mitochondrial energy production.
Energy metabolism and tumor growth
- Warburg identified insufficient respiration and compensatory fermentation through glucose-derived lactate.
- Glutamine fermentation adds a second major fuel stream, producing succinate in damaged mitochondria.
- Glucose and glutamine supply ATP, carbons, and nitrogen for membranes, proteins, nucleotides, lipids, and other biomass.
- Lactic and succinic acid create an acidic microenvironment that supports invasion and weakens drug and immune effects.
- Reactive oxygen species arise downstream from damaged respiration and can produce the mutations seen in tumor genomes.
Cancer hallmarks from damaged mitochondria
- Cell-cycle disorder follows mitochondrial effects on nuclear gene expression and regulatory control.
- Loss of contact inhibition follows calcium and adhesion defects at the tumor-cell surface.
- Angiogenesis follows HIF-1 alpha and c-MYC opening glucose and glutamine transport pathways.
- Failed apoptosis follows dysfunction in the organelle that normally controls programmed cell death.
- Metastasis follows fusion between a cancer stem cell and a macrophage-like immune cell, creating a mobile glucose- and glutamine-driven cell.
Metabolic management strategy
- Management requires lowering glucose and glutamine while raising fatty acids and ketones.
- Cancer cells cannot rely on fatty acids or ketone bodies when glucose and glutamine are unavailable.
- Water-only fasting, calorie restriction, low-carbohydrate diets, ketogenic diets, ketone supplements, exercise, stress control, hyperbaric oxygen, and pulse drugs fit this strategy.
- The glucose ketone index tracks the glucose-to-ketone ratio, with values near or below 2.0 used as the therapeutic zone.
- Press-pulse therapy uses chronic metabolic pressure plus timed pulses against glucose and glutamine dependence.
Preclinical evidence
- In an aggressive mouse brain-tumor model, 40% calorie restriction on the same high-carbohydrate diet reduced tumor size by 65% to 80%.
- Higher blood glucose tracked with larger and faster tumors, while lower glucose tracked with slower tumor growth, lower inflammation, fewer abnormal vessels, and more tumor killing.
- Calorie-restricted ketogenic diet plus pulsed DON produced far better survival in late-stage experimental glioblastoma than either diet or DON alone.
- A juvenile high-grade glioma model used restricted ketogenic diet, mebendazole, and glucose-glutamine targeting, with longer survival and better quality of life.
Human and animal cases
- Glioblastoma outcomes have barely improved, and standard surgery, radiation, chemotherapy, and steroids can increase glucose, glutamine, inflammation, and metabolic stress.
- The Alexandria glioblastoma case combined fasting, restricted ketogenic diet, awake craniotomy, modified standard care, and hyperbaric oxygen, with 24-month follow-up publication.
- Brittany Maynard is used as a standard-care contrast case: young glioblastoma patient, steroid effects, and medically assisted death in 2014.
- Pablo Kelly used ketogenic metabolic therapy without chemotherapy or radiation, tracked glucose and ketones for years, and lived 122 months after diagnosis.
- The Greece glioblastoma study pairs standard care with ketogenic metabolic therapy; four of six adherent patients lived at least three years versus one of twelve in the standard-care group.
- Triple-negative breast cancer, lung cancer, prostate cancer, and canine mast-cell tumor examples are used as broader applications of the same metabolic strategy.
Closing thesis
- Cancer management should avoid fatalistic terminal language when metabolic options remain.
- Mitochondria, not the nucleus, belong at the center of cancer origin and management.
- Substrate-level phosphorylation through glucose and glutamine fermentation drives dysregulated growth.
- The future cancer program is press-pulse metabolic therapy: lower glucose and glutamine, elevate ketones, and use coordinated metabolic tools.
References
- [00:00] Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer — https://doi.org/10.1002/9781118310311
- [02:00] Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory? — https://doi.org/10.3390/metabo11090572
- [03:00] Hallmarks of Cancer: The Next Generation — https://doi.org/10.1016/j.cell.2011.02.013
- [06:00] Transplantation of Pluripotential Nuclei from Triploid Frog Tumors — https://doi.org/10.1126/science.165.3891.394
- [07:00] Mouse Embryos Cloned from Brain Tumors — https://aacrjournals.org/cancerres/article/63/11/2733/510012/Mouse-Embryos-Cloned-from-Brain-Tumors1
- [08:00] Reprogramming of a Melanoma Genome by Nuclear Transplantation — https://doi.org/10.1101/gad.1213504
- [10:00] What Is Cancer? — https://www.cancer.gov/about-cancer/understanding/what-is-cancer
- [11:00] On the Origin of Cancer Cells — https://doi.org/10.1126/science.123.3191.309
- [18:00] The Living State and Cancer — https://doi.org/10.1073/pnas.74.7.2844
- [21:00] Cancer as a Metabolic Disease — https://doi.org/10.1186/1743-7075-7-7
- [21:00] Cancer as a Metabolic Disease: Implications for Novel Therapeutics — https://doi.org/10.1093/carcin/bgt480
- [21:00] Cancer as a Mitochondrial Metabolic Disease — https://doi.org/10.3389/fcell.2015.00043
- [22:00] The Calorically Restricted Ketogenic Diet, an Effective Alternative Therapy for Malignant Brain Cancer — https://doi.org/10.1186/1743-7075-4-5
- [23:00] The Glucose Ketone Index Calculator: A Simple Tool to Monitor Therapeutic Efficacy for Metabolic Management of Brain Cancer — https://doi.org/10.1186/s12986-015-0009-2
- [25:00] Press-Pulse: A Novel Therapeutic Strategy for the Metabolic Management of Cancer — https://doi.org/10.1186/s12986-017-0178-2
- [26:00] Therapeutic Benefit of Combining Calorie-Restricted Ketogenic Diet and Glutamine Targeting in Late-Stage Experimental Glioblastoma — https://doi.org/10.1038/s42003-019-0455-x
- [29:00] Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up — https://doi.org/10.3389/fnut.2018.00020
- [30:00] Terminally Ill Woman Brittany Maynard Has Ended Her Own Life — https://people.com/celebrity/terminally-ill-woman-brittany-maynard-has-ended-her-own-life/
- [31:00] Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report — https://doi.org/10.3389/fnut.2021.682243
- [33:00] Successful Application of Dietary Ketogenic Metabolic Therapy in Patients With Glioblastoma: A Clinical Study — https://doi.org/10.3389/fnut.2024.1489812
- [35:00] Ketogenic Diet as a Metabolic Vehicle Enhancing the Therapeutic Efficacy of Mebendazole and Devimistat in Juvenile Syngeneic High-Grade Glioma — https://doi.org/10.1016/j.xcrm.2026.102845
- [35:00] Efficacy of Metabolically Supported Chemotherapy Combined With Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer — https://doi.org/10.7759/cureus.1445
- [36:00] Restricted Ketogenic Diet Therapy for Primary Lung Cancer With Metastasis to the Brain: A Case Report — https://doi.org/10.7759/cureus.27603
- [36:00] Clinical Research Framework Proposal for Ketogenic Metabolic Therapy in Glioblastoma — https://doi.org/10.1186/s12916-024-03775-4
- [37:00] Case Report: Resolution of Malignant Canine Mast Cell Tumor Using Ketogenic Metabolic Therapy Alone — https://doi.org/10.3389/fnut.2023.1157517
Ok I watched the video and its exactly what I expected. And to be clear, what I expected when I read the summary of the video, before I read that critique (it's why I looked up the critique).
He makes very strong claims. You said "Seyfried’s diet position is fairly straightforward - there is no downside to not feeding glucose into cancer that thrives on glucose.". That isn't his position in this video at all! He literally says "We understand cancer and we know how to manage cancer". He ridicules the rest of the field and compares himself to Copernicus. His reasoning for claiming that "scientists don’t read the papers" seems to be that if they'd read them then they would obviously agree with him?! He is extremely aggressively saying that he is right and almost everyone else is wrong.
And what's his evidence for this extraordinary claim? Some trials on mice and what amounts to anecdotes on a few individual cases, and the giloblastoma study. Which certainly seems promising! But is a tiny sample size, and that study itself describes its results as "encouraging"; hardly strong proof.
The critique's from the article I linked seem exactly as valid now as they were when it was written. There certainly seems like some promising paths of investigation in this field, but Seyfried is going way over the top with his claims. And I mean, those single cases that he presents in this video are a huge red flag, that just isn't science and isn't how a legitimate scientist presents evidence.
Yup, early days, but it isn't contradicted by observed data - which makes the mitochondrial metabolic theory of cancer interesting. There are a few (8 i think) ongoing glioblastoma studies being run independently of Seyfried in NZ I think - so I wait to see those results. the press-pulse protocol paper is being used in some AU studies at the moment as well.
My main concern with that article is that it isn't peer reviewed, the author is no stranger to publishing papers (100+ i could find), so why not publish his critique?
I think part of the problem is his smoking gun - https://doi.org/10.3892/ijo.2014.2382 - didn't actually use a ketogenic diet - 60g a day of carbs isn't therapeutic levels of ketosis (i.e. many people wont be in ketosis at this level), and they measured with urine strips - in 2014!!! - that's crazy. so they couldn't compute the GKI, which was a cornerstone of Seyfried's (at the time) kmt protocol.
As far as the human interventions go there is only the one published intervention - 6 patients - https://doi.org/10.3389/fnut.2024.1489812 - Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study
There are a bunch of case studies (about 15 in total i think), which I'm sure you saw.
about 40 patients demonstrating keto was well tolerated during standard of care treatment in other studies.
and about 18 KMT papers where seyfried isn't directly involved, covering about 250 patients, all basically saying its tolerated as well.
none of this contradicts the mitochondrial metabolic theory of cancer. so yeah, if Gorski wants to hang onto the somatic mutation theory of cancer that is fine, but he doesn't actually have anything interesting to say about the metabolic theory other then he wants more data - whooptidoo - every theory and study wants more data.
It is when your close to retirement age and you don't worry about tenure and committees anymore. His papers haven't been retracted, which is the key point, and his human study protocols are implemented in ongoing trials. So his theory is interesting and worth thinking about, and not dismissing - even if you don't like someone if they have a theory that makes predictions with measurable outcomes - it's interesting.
It's definitely interesting and I'll keep an eye on it. I still think Seyfried's way overstating his case and there's a lot of potential for bad outcomes from it, especially in the current climate around medicine.
I don't see any downsides to people reducing glucose when they are worried about cancer.
As far as the KMT, it should be combined with a physician anyway, so not much risk of people doing it DIY since the drugs are prescription only.
As far as downvotes in this community go - downvotes are not a disagree button, it's a signal something is bad for the community. downvoting a interesting post you want to keep your eye on future developments of sends me mixed signal.
The downvcote is because I think this is a bad video to communicate this area of research. As I've said, Seyfried's claims are way over the top and I don't think accurately inform on the science.